Skip to main content

Physician Search

 


Displaying 1 - 6 of 6

A Phase II Study of Neoadjuvant Nivolumab plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma.

Not Available
II
Ciombor, Kristen
NCT04751370
ECOGGIEA2201

Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)

Kidney (Renal Cell)

Kidney (Renal Cell)
II
Rini, Brian
NCT05361720
VICCURO21103

A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

Multiple Cancer Types

Esophageal, Gastric/Gastroesophageal
II/III
Gibson, Mike
NCT03604991
ECOGGIEA2174


A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma

Multiple Cancer Types

Lymphoma, Phase I
I
Friedman, Debra
NCT01896999
COGE4412

Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma

Melanoma

Melanoma
II/III
Johnson, Douglas
NCT02339571
ECOGMELEA6141